Articles tagged with Cellular Reprogramming
Scientists have uncovered a new mechanism used by heart cells to resist reprogramming and found that carbohydrate sulfotransferase 7 (CHST7) is the most potent preventer of reprogramming in mouse and human cells. By targeting CHST7, researchers may develop treatments to help the heart fix itself after injury.
Researchers at Pohang University of Science & Technology discovered a way to prime skin cells for regeneration before injury, enabling rapid and effective healing. This approach, called mosaic partial reprogramming, reshapes surrounding cells and tissue microenvironment to accelerate wound healing.
Scientists at Lund University have created a new method to directly reprogram glial cells into parvalbumin neurons, which can help regulate brain activity and potentially treat disorders such as schizophrenia and epilepsy. The breakthrough could lead to therapies that replace lost or damaged brain cells in the future.
The study uses Rapid Precision Run-On Sequencing (rPRO-seq) to uncover molecular drivers of cellular differentiation, offering a paradigm shift in understanding regenerative therapies. The technique allows doctors to analyze patients' disease states and treatment response in real-time.
Researchers at the University of Pennsylvania have developed a protein called Melt that can be toggled by temperature, allowing for precise control over cellular pathways. The breakthrough enables non-invasive therapy options for cancer treatment and basic research, potentially leading to more targeted and less toxic treatments.
A team of researchers at the University of Toronto has discovered a unique stem cell type, the neural crest stem cell, which can be reprogrammed into different cell types. This discovery challenges longstanding theories in cellular reprogramming and highlights the potential of these cells for stem cell transplantation to treat disease.
Researchers at the University of Barcelona have developed a method to rejuvenate brain neurons in mice using controlled cellular reprogramming cycles with Yamanaka factors. This process recovers altered neurological properties and functions, and has been shown to increase neuron count and brain plasticity.
Researchers have discovered how pioneer transcription factors, such as FOXA and OCT4, coordinate with epigenetic repressors to safeguard cell fate, enabling precise manipulation of cell fate in cellular programming and reprogramming. This breakthrough has important implications for scaling up organoid and tissue engineering technology.
Researchers at IRB Barcelona found that vitamin B12 is essential for cellular reprogramming and tissue repair, improving reprogramming efficiency. The study also shows promise for treating ulcerative colitis by supplementing with vitamin B12.
Researchers found that enteroendocrine cells in Drosophila intestinal epithelium undergo dedifferentiation into intestinal stem cells in response to nutritional changes, such as recovery from starvation. This process is vital for ISC expansion and subsequent intestinal growth following food intake.
Scientists have developed a new method to deliver genetic information to stem cells using nanoparticles coated with a specific polymer, enabling more efficient control over cellular differentiation. This innovation has the potential to improve the efficiency and effectiveness of regenerative medicine treatments.
Using mice, researchers successfully converted scar tissue back into functioning cardiac muscle using RNAs and exosomes, offering new hope for reversing heart attack damage. The study also sheds light on the aging process's impact on cellular reprogramming.
Researchers at Sanford Burnham Prebys have identified a group of proteins called AJSZ that help solve a known problem in cellular reprogramming. By blocking the activity of these proteins, they were able to reduce scarring on the heart and induce a 50% improvement in overall heart function in mice that have undergone a heart attack.
A study uses cellular reprogramming to create neural networks with unique human cell characteristics, demonstrating potential for new therapies and reduced animal experimentation. The research reveals differences in neuronal circuit behavior between human and rodent cells.
Cardiac reprogramming converts scar tissue into healthy heart muscle, reducing fibrosis and improving heart function in mice with chronic myocardial infarction. This approach could lead to a new treatment for patients with heart attack and heart failure.
Researchers have found a way to partially reset liver cells to more youthful states, allowing them to heal damaged tissue at a faster rate than previously observed. The use of reprogramming molecules improves cell growth and leads to better liver tissue regeneration in mice.
Researchers have successfully rejuvenated mouse organs through cellular reprogramming, improving their health and potential applications for cell therapy. The study identified key changes in metabolism, gene expression, and DNA status during aging, which are partially reversed by reprogramming.
A recent study by Gladstone Institutes researchers found that mouse stem cells can spontaneously transition from heart cell precursors to brain cell precursors when a specific gene is removed. This discovery upends current understanding of how stem cells differentiate into adult cells and maintain their identity. The study's findings h...
Researchers used partial cellular reprogramming to reduce signs of aging and extend lifespan in mice with premature aging mutations. The approach altered epigenetic changes, suggesting that aging is a plastic process.
Researchers at CNIO found that tissue damage enables cells to adopt embryonic features through the OSKM gene system, mediated by proinflammatory molecule IL-6. This discovery could improve regenerative medicine and treatment of degenerative diseases.
Researchers have identified a mechanism by which cells undergo reprogramming in live mice, utilizing neighboring cells to trigger reprogramming. This process involves the secretion of proteins, including an inflammatory cytokine, that promote the reprogramming of adjacent cells.
Researchers developed an algorithm called Mogrify that predicts the unique set of cellular factors required for converting one human cell type to another. This breakthrough has significant implications for regenerative medicine and lays the groundwork for further research into cell reprogramming.
A study reveals that SIRT1 is required for correct and safe cell reprogramming, ensuring healthy functioning of induced pluripotent stem cells. The protein helps maintain telomeres and prevents chromosome aberrations and DNA damage.
Li Qian, an assistant professor at the University of North Carolina School of Medicine, has received a New Scholar in Aging Award from the Ellison Medical Foundation. The award provides four years of funding to support her research on regenerating or repairing injured heart cells.